Of note, anti-CD47 therapies promote M1 polarization and phagocytosis of cancer cells by both M1 and M2 macrophages, with more prominent phagocytosis by M1 than M2 [27], reversely to what we observed here with VISTA. This evidence concerns the gene CD47 and cancer.